Clinical Trial Update: First-line Therapy in Metastatic PDAC [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update investigating first-line therapy for metastatic pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: Ludwig-Maximilians - University of Munich | Conditions: Metastatic Pancreatic Cancer | Phase 2 | Status: UNKNOWN